GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain
1 other identifier
observational
2,200
1 country
1
Brief Summary
GLA:D Back is a program developed in Denmark to help people with persistent low back pain. This study will assist in contextualizing Danish content into an English version of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2021
CompletedFirst Submitted
Initial submission to the registry
April 5, 2025
CompletedFirst Posted
Study publicly available on registry
April 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
April 13, 2026
April 1, 2026
5.6 years
April 5, 2025
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Implementation
Number of clinicians who implement the program
6 months
Secondary Outcomes (1)
Patients enrolled
6 months
Interventions
GLA:D Back is a 10-week program based on first-line recommendations of patient education and structured exercise taught in a group format.
Eligibility Criteria
English speaking adults greater than 18 years of age.
You may qualify if:
- Patients must have persistent low back pain of at least 1 month's duration.
You may not qualify if:
- Participating currently in a supervised exercise or rehabilitation program or enrolled in another interventional clinical trial.
- Patients with nerve root involvement, suspected serious pathology, unstable trauma to the spine, aspects of pregnancy or other conditions that would prevent participation or disallow trial completion within the prescribed time period.
- Persons with conditions that require a specialist consult are suspected of needing a specialist consult, or have conditions that would be aggravated or worsened if treated by the interventions in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alberta
Edmonton, Alberta, T6G 2G4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2025
First Posted
April 11, 2025
Study Start
June 18, 2021
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share